Delve Detect delivers 22 percent greater diagnostic yield with results the next day, offering an important new tool for managing complex central nervous system infections, including co-infection and ...
Data further support choice of patient population and dosing regimen in CervoMed's planned Phase 3 trial in dementia with Lewy bodies (DLB) DLB is the second most common progressive dementia, ...
Quantitative analysis of breast parenchymal background enhancement (BPE) on magnetic resonance (MR) imaging: Association with mammographic breast density and aggressiveness of the primary cancer in ...
When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...
In healthcare, pathology is like detective work. Pathologists meticulously examine tissues and cells to uncover the underlying causes of patients' health problems. With the global market for pathology ...
The presentations will be shared at the Association for Molecular Pathology (AMP) 2025 Annual Meeting in Boston. “Real-world experience underscores what our data show: Delve Detect CSF provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results